Karim Thomas Sadak1, Joseph P Neglia1, David R Freyer2,3, Eileen Harwood4. 1. University of Minnesota Masonic Children's Hospital, University of Minnesota Masonic Cancer Center, Minneapolis, Minnesota. 2. Children's Center for Cancer and Blood Diseases, Children's Hospital Los Angeles, Los Angeles, California. 3. Division of Hematology, Oncology and Blood and Marrow Transplantation, Department of Pediatrics, Keck School of Medicine, University of Southern California, Los Angeles, California. 4. Division of Epidemiology & Community Health, University of Minnesota School of Public Health, Minneapolis, Minnesota.
Abstract
BACKGROUND: Long-term survival in childhood cancer is excellent. Most survivors will have a therapy-related chronic condition, yet very few receive survivor-focused care as they transition from adolescence to young adulthood. The purpose of this study is to identify indicators of success in current transitional care practices for young adult survivors of childhood cancer as defined by all members of survivorship care teams. PROCEDURE: An exploratory, phenomenologic qualitative study was conducted with key informants from medical teams involved in transitional care of childhood cancer survivors. Data were collected through phone interviews with providers from both pediatric and adult care settings. RESULTS: A multidisciplinary study sample of 29 participants from three institutions identified two major themes with multiple subthemes. The first major theme was that providers must be good communicators, and it emphasized the importance of having good relationships throughout the transition of care to optimize effective communication. The second major theme was that models of care must include well-established partners throughout the healthcare system that promote accessible subspecialty care with streamlined referrals and patient navigation services. CONCLUSIONS: From the perspective of experienced pediatric- and adult-centered providers at three different institutions delivering life-long transitional care for childhood cancer survivors, the optimal model of care must be built around facilitating communication among all key stakeholders and emphasizing patient-friendly services that minimize patient stressors.
BACKGROUND: Long-term survival in childhood cancer is excellent. Most survivors will have a therapy-related chronic condition, yet very few receive survivor-focused care as they transition from adolescence to young adulthood. The purpose of this study is to identify indicators of success in current transitional care practices for young adult survivors of childhood cancer as defined by all members of survivorship care teams. PROCEDURE: An exploratory, phenomenologic qualitative study was conducted with key informants from medical teams involved in transitional care of childhood cancer survivors. Data were collected through phone interviews with providers from both pediatric and adult care settings. RESULTS: A multidisciplinary study sample of 29 participants from three institutions identified two major themes with multiple subthemes. The first major theme was that providers must be good communicators, and it emphasized the importance of having good relationships throughout the transition of care to optimize effective communication. The second major theme was that models of care must include well-established partners throughout the healthcare system that promote accessible subspecialty care with streamlined referrals and patient navigation services. CONCLUSIONS: From the perspective of experienced pediatric- and adult-centered providers at three different institutions delivering life-long transitional care for childhood cancer survivors, the optimal model of care must be built around facilitating communication among all key stakeholders and emphasizing patient-friendly services that minimize patient stressors.
Authors: Christina Signorelli; Claire E Wakefield; Joanna E Fardell; Tali Foreman; Karen A Johnston; Jon Emery; Elysia Thornton-Benko; Afaf Girgis; Hanne C Lie; Richard J Cohn Journal: Oncologist Date: 2018-08-31
Authors: Karim Thomas Sadak; Milki T Gemeda; Michelle Grafelman; Joseph P Neglia; David R Freyer; Eileen Harwood; Jude Mikal Journal: BMC Cancer Date: 2020-09-21 Impact factor: 4.430
Authors: Joel Milam; David R Freyer; Kimberly A Miller; Jessica Tobin; Katherine Y Wojcik; Cynthia N Ramirez; Anamara Ritt-Olson; Stefanie M Thomas; Lourdes Baezconde-Garbanati; Michael Cousineau; Denise Modjeski; Sapna Gupta; Ann S Hamilton Journal: JNCI Cancer Spectr Date: 2021-07-17
Authors: Karim Thomas Sadak; Milki Gemeda; Michelle C Grafelman; Taiwo O Aremu; Joseph P Neglia; David R Freyer; Eileen Harwood; Jude Mikal Journal: Cancer Med Date: 2021-08-06 Impact factor: 4.452